Every UK aesthetic practitioner I speak to has heard that licensing is coming. Almost none of them can tell me, with confidence, what the licensing scheme actually requires of them, when the requirements bite, and what they should be doing today to be ready.
This is not the practitioners' fault. The legislation was passed in 2022. The consultation closed in 2023. The response was published. The detailed regulations, the specific tier definitions, and the local authority enforcement structures have followed in stages, and the trade press has reported them in fragments rather than as a coherent whole. The result is a low-grade anxiety across the sector that hardens into denial in some practitioners and panic in others, neither of which is the right response.
This post is the read-out I give inside the RAG Pathway when this comes up. It is the legislative spine of where the scheme sits, what the consultation response has signalled, what practitioners should be doing now, and how to think about it without losing sleep.
The legislative spine
The licensing scheme has its statutory basis in Section 180 of the Health and Care Act 2022. The Act gives the Secretary of State for Health and Social Care the power to introduce regulations requiring a licence to perform specified non-surgical cosmetic procedures in England. The Act itself is short. The substance lives in the regulations made under it, and that is where most practitioners get lost.
The key features the Act establishes are:
- It applies to England only. Scotland and Wales have separate regulatory pathways. Practitioners working across borders need to know both.
- It applies to procedures performed on people aged eighteen and over. Procedures on under-eighteens are already prohibited under the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, regardless of who performs them.
- It establishes a licensing requirement for both the practitioner and the premises. Two licences, not one. This is a structural feature people miss.
- It empowers local authorities to administer and enforce. The detail of how this lands in your specific local authority will vary, and the costs and timelines will not be uniform across England.
That is the legal anchor. Everything below is downstream of that.
What the consultation has told us
The Department of Health and Social Care consultation on the scope and structure of the scheme closed in 2023, and the response signalled the framework that the regulations are now built around. Three structural features have emerged with reasonable clarity.
A risk-based, tiered scope. The scheme is being structured as a three-tier classification. The tiers correspond to procedural risk. The lower tier captures lower-risk treatments and has lighter premises and oversight requirements. The middle tier captures moderate-risk treatments and adds clinical oversight requirements. The upper tier, the highest-risk procedures, will require the procedure to be performed by, or under the direct supervision of, a regulated healthcare professional.
The procedure-by-procedure assignment to tier is exactly the place where the trade press has been most volatile, because the assignment changes both the cost structure of practising and the workforce that can lawfully perform the procedure. Watch the final regulations rather than the trade press summaries.
Premises standards. The scheme will set baseline standards for the physical environment in which the procedures are performed. This includes infection control, waste handling, sharps management, emergency equipment, and record-keeping. Most practitioners running a properly equipped clinical room are already broadly compliant, but the gap is documentation: showing you meet the standard rather than asserting it.
Practitioner standards. Training, qualifications, indemnity insurance, and continuing professional development are all in scope. The detail varies by tier, with the higher-risk tiers requiring the practitioner to be regulated by a statutory healthcare regulator (NMC, GMC, GDC, GPhC, HCPC) and to operate within the scope of their professional registration.
The framework, in short, codifies what already-good practitioners do. It also codifies who can lawfully do what, which is the part that changes the workforce.
What this means for nurses, doctors, dentists, and unregulated practitioners
The blunt summary, which I am happy to give because it is the consistent direction of travel from the consultation, the JCCP, and Save Face, is this.
Statutorily regulated healthcare professionals (registered nurses, doctors, dentists, midwives, pharmacists, certain HCPC roles) will be best placed under the scheme. Your existing professional registration, indemnity, prescribing pathway, and CPD framework already meet the practitioner-side requirements for the higher tiers. The work is around premises standards, documentation, and tier-specific clinical oversight where you are the supervisor.
Independent prescribers. If you are prescribing prescription-only medicines for cosmetic indications, the scheme will sit alongside, not replace, the existing prescribing rules. The face-to-face consultation requirement for cosmetic prescribing has been steadily tightened by the General Pharmaceutical Council and the Royal Pharmaceutical Society, and that direction is unlikely to reverse.
Unregulated practitioners working in higher-risk tiers will face the most material change. Where the regulations land on the upper tier, the lawful workforce contracts. Practitioners in this position have three honest options: route through to a statutory healthcare qualification, restrict practice to lower-tier procedures the regulations permit them to perform, or work under the direct supervision of a regulated healthcare professional in a model that the regulations recognise.
This is uncomfortable to read for some practitioners. It is the direction the regulations are moving, and the practitioners who plan early will adapt better than the practitioners who hope the scheme will be diluted.
What you should be doing today
You do not need to wait for the final commencement date to start preparing. The work that compounds well in advance is also the work that protects you under the existing JCCP, ASA, and indemnity regimes, so none of it is wasted.
Document everything. Consent forms, treatment records, batch numbers, photographs, complications log, training certificates, indemnity policy. Every gap you have today is the gap a licensing inspector will find tomorrow. The single highest-leverage move is bringing the documentation up to a standard you would happily show under inspection.
Audit your premises against infection-control and clinical-environment standards. Sharps, waste, hand hygiene, surface decontamination, drug storage, emergency equipment, anaphylaxis kit, vascular occlusion crash kit. The standards are not yet final, but they are not going to be looser than the existing CQC clinical-environment baseline. Aim there.
Confirm your prescribing pathway is clean. Whether you prescribe yourself, or you operate under a prescribing collaboration with a colleague, get the relationship documented, get the consultation arrangement compliant with the latest GPhC and RPS guidance, and stop relying on convenience. Remote-only cosmetic prescribing without an appropriate face-to-face consultation has been the most common compliance failure in the last two years.
Join an accredited register. The JCCP and Save Face registers are the two most-cited in the consultation responses and are the most likely to be referenced by the regulations as evidence of practitioner standards. They are not licensing in themselves, but they are the closest current proxy for the standards the regulations will codify.
Update your advertising. The ASA has been ruling against cosmetic injectable advertising at increasing frequency. Your social media, your website, your treatment-list pricing, and your before-and-after content all need to be ASA-compliant before they need to be licensing-compliant. Fix advertising first.
Commit to a CPD log. A documented programme of continuing professional development, with the courses, dates, hours, and reflective notes, is the simplest way to evidence the practitioner-side standards under any tier of the scheme.
What I am doing inside Visage Aesthetics
Because practitioners ask, this is what I am doing inside my own clinic in the run-up.
Premises and equipment audited against the existing CQC clinical-environment baseline, even though the clinic is not CQC-registered, because the licensing premises standards are not going to be lighter than that.
All practitioners on the JCCP register and Save Face register, indemnity policies up to date, NMC registration verifiable on the public register.
Prescribing pathway documented, with face-to-face consultations for any prescription-only cosmetic medicine and a written prescribing protocol filed for inspection.
Documentation system rebuilt around the assumption that any record may be inspected at any time, with photographs, consent, batch numbers, and complications all stored securely for ten years.
Advertising audited every quarter against the latest ASA rulings.
CPD log maintained for the clinic and for me personally, with the expectation that a higher-tier procedure list will require evidence of ongoing training in those specific procedures.
None of this is licensing-specific work. All of it is the work that good practitioners do anyway. The licensing scheme will codify it, and the practitioners who built it in advance will keep practising calmly while others scramble.
Why this matters
The licensing scheme is the biggest regulatory event UK aesthetics has seen, and the trade press will continue to oscillate between alarm and dismissal until the final regulations land. Neither is the right response. The right response is to read the legislation, track the consultation, build the documentation now, and keep practising at a standard you would happily defend.
The practitioners who do that come out of the licensing transition strong. The practitioners who wait for certainty before they prepare will not have time to do the work once certainty arrives.
Continue your reading
The four-week deep dive on the licensing scheme, the prescribing rules, the JCCP and ASA frameworks, and the inspection-ready documentation system sits inside the RAG Pathway. For the regulator-by-regulator standards we teach against, including the eight UK bodies and the specific clauses each enforces, see the standards we teach against. For a wider read on UK aesthetics regulation, the regulation overview is the index page that links every regulator into one map.
Bernadette Tobin is a Registered Nurse and Independent Nurse Prescriber with an MSc in Advanced Practice (Level 7). She is the founder of Aesthetics Unlocked and a 2026 Educator of the Year Nominee at the Beauty & Aesthetics Awards. She runs Visage Aesthetics in Essex, named Best Non-Surgical Aesthetics Clinic 2026 by the Health, Beauty & Wellness Awards. Verifiable on the NMC public register.